Prostatype Genomics AB (publ)
Stockholm Stock Exchange PROGEN.ST
Prostatype Genomics AB (publ) Share Price on January 14, 2025: USD 0.80
Prostatype Genomics AB (publ) Share Price is USD 0.80 on January 14, 2025, a -92.04% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
-
Prostatype Genomics AB (publ) 52-week high Share Price is USD 10.07 on January 15, 2024, which is 1,156.24% above the current Share Price.
-
Prostatype Genomics AB (publ) 52-week low Share Price is USD 0.62 on November 27, 2024, which is -23.23% below the current Share Price.
-
Prostatype Genomics AB (publ) average Share Price for the last 52 weeks is USD 2.96.
Key data
| Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
|---|
Market news
Loading...
Stockholm Stock Exchange: PROGEN.ST
| CEO | Mr. Fredrik Rickman |
| IPO Date | Nov. 3, 2020 |
| Location | Sweden |
| Headquarters | Industrivägen 19 |
| Employees | 6 |
| Sector | Health Care |
| Industries | |
Description
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The test is based on database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision. The company was founded in 2007 and is based in Solna, Sweden.
Key trends
Past 5 years
Similar companies
Sprint Bioscience AB (publ)
USD 0.14
1.34%
StockViz Staff
January 15, 2025
Any question? Send us an email